FGF-2 Enhances Chondrogenesis in Human Mesenchymal Stem Cells
Author Information
Author(s): Andrew M. Handorf, Wan-Ju Li
Primary Institution: University of Wisconsin-Madison
Hypothesis
FGF-2 primes human mesenchymal stem cells (hMSCs) for enhanced chondrogenesis by increasing Sox9 protein levels.
Conclusion
FGF-2 treatment significantly enhances the differentiation of hMSCs into chondrocytes by increasing Sox9 protein levels.
Supporting Evidence
- FGF-2 increased Sox9 protein levels in hMSCs within 30 minutes of exposure.
- Chondrogenic differentiation was enhanced in hMSCs expanded in FGF-2-supplemented medium.
- FGF-2 treatment led to significant upregulation of cartilage-specific gene expression.
Takeaway
FGF-2 helps special cells in our body called stem cells turn into cartilage cells better by making a protein called Sox9 that is important for this process.
Methodology
Human mesenchymal stem cells were expanded in medium with or without FGF-2 and then induced to differentiate into chondrocytes, with gene and protein expression analyzed.
Limitations
The study does not fully elucidate the underlying signaling mechanisms by which FGF-2 enhances chondrogenesis.
Participant Demographics
Human patients undergoing total hip replacement surgery provided bone marrow-derived hMSCs.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website